Oxytetracycline depletion and withdrawal time estimation following intraperitoneal administration in three species from Chilean salmon farming

This study was conducted to evaluate the half‐time (T½) and withdrawal time (WT) of oxytetracycline (OTC) following intraperitoneal (i.p.) administration of OTC (24.8–34.7 mg/kg) in three farmed salmonid species, Coho salmon (Oncorhynchus kisutch), Rainbow trout (Oncorhynchus mikiss) and Atlantic salmon (Salmo salar). A detection technique in fish skin muscle through a high‐performance liquid chromatography (HPLC) with a diode array detector (DAD) was developed and validated. The depletion studies were carried out in controlled conditions (nine studies) and under field conditions (one study). The T½ and WT estimations from the skin muscle after the i.p. administration of OTC in salmonids appear to be longer than studies where the OTC was orally administrated. Furthermore, the OTC maximum concentration in muscle seems to be also higher in the i.p. treatment. Due to the prolonged WT following the i.p. OTC administration, cautions related to the salmon harvest time should be consider in order to prevent OTC traces in the final product.     

Sensitivity of Tilapia (Oreochromis mossambicus) to Clostridium botulinum toxins

The sensitivity of Oreochromis mossambicus to Clostridium botulinum toxin types A–E was investigated. All five toxin types were toxic to O. mossambicus. In the case of toxin types A–D, O. mossambicus was considerably more resistant than mice and, in the case of type E toxin, fish were more sensitive. The minimum intraperitoneal (i.p.) dose of type E toxin for fish was half the minimum lethal dose for mice. The results of the study suggest that good hygiene should be maintained in fish/shrimp farms to keep contamination at a low level.     

Effect of route of administration and carrier on bioavailability and kinetics of astaxanthin in Atlantic salmon Salmo salar L.

This study examined astaxanthin bioavailability and kinetics in adult Atlantic salmon Salmo salar L., following two different routes of astaxanthin administration (oral vs. intraperitoneal (i.p.) injection) using two different carriers of the pigment (gelatin vs. sesame oil). The dorsal aorta of adult Atlantic salmon (mean initial weight 950 g) was cannulated. The fish received a single dose of astaxanthin (572 μg kg^?1) in sesame oil or (514 μg kg^?1) in gelatin via the oral or i.p. route. Plasma was sampled regularly up to 72 h post oral administration and up to 510 h post i.p. injection. The astaxanthin concentration–time curves from plasma were best fit to a one‐compartment pharmacokinetic model for each of the four treatments. The gelatin carrier resulted in higher availability of astaxanthin compared to the sesame oil carrier. The bioavailability for astaxanthin in sesame oil was only 38.7% of that in gelatin by i.p. injection, and only 53.5% of that in gelatin by oral administration. Higher availability of astaxanthin was observed when i.p. injection was used compared to oral administration. The bioavailability for astaxanthin administered orally was only 12% of that by i.p. injection in sesame oil, and only 8.7% of that by i.p. injection in gelatin.     

Multiple passage of infectious salmon anaemia virus in rainbow trout,Oncorhynchus mykiss (Walbaum), did not induce increased virus load

The infectious salmon anaemia virus (ISAV) has not been observed to cause natural disease in farmed rainbow trout, Onchorhynchus mykiss (Walbaum), but may cause high mortality in farmed Atlantic salmon, Salmo salar L. In this study, ISAV was passaged 10 times in succession by intraperitoneal injections of serum from previous passage into naïve rainbow trout. The serum viraemia was monitored by real‐time qPCR. The rainbow trout in this study became infected but did not develop ISA. No clinical signs were observed in the rainbow trout in any passage, but replication of ISAV was detected from Day 4 post‐infection (p.i.). Neither increased relative virus loads nor histopathological and immunohistochemical findings consistent with ISA were observed. However, the expression of interferon type I and Mx genes were slightly up‐regulated in the hearts of some individual fish at day 17 p.i. Sequencing of all open reading frames in the ISAV genome of the 10th passage revealed two nucleotide mutations, one in segment 6 coding for the haemagglutinin–esterase (HE) and one in segment 1 coding for the basic polymerase 2 (PB2). The mutation in HE resulted in an amino acid substitution T/K₃₁₂.     

Vibrogen‐2 vaccine trial in lumpfish (Cyclopterus lumpus) against Vibrio anguillarum

Lumpfish (Cyclopterus lumpus), a native fish of the North Atlantic Ocean, is utilized as cleaner fish to biocontrol sea lice infestations in Atlantic salmon aquaculture. However, bacterial infections are affecting cleaner fish performance. Vibrio anguillarum, the aetiological agent of vibriosis, is one of the most frequent bacterial infections in lumpfish, and effective vaccine programmes against this pathogen have been identified as a high priority for lumpfish. Vibrogen‐2 is a commercial polyvalent bath vaccine that contains formalin‐inactivated cultures of V. anguillarum serotypes O1 and O2, and Vibrio ordalii. In this study, we evaluated Vibrogen‐2 efficacy in lumpfish against a local isolated V. anguillarum strain. Two groups of 125 lumpfish were bath‐immunized, bath‐boost‐immunized at four weeks post‐primary immunization, and intraperitoneally (i.p.) boost‐immunized at eight weeks post‐primary immunization. The control groups were i.p. mock‐immunized with PBS. Twenty‐seven weeks post‐primary immunization, the fish were i.p. challenged with 10 or 100 times the V. anguillarum J360 LD₅₀ dose. After the challenge, survival was monitored daily, and samples of tissues were collected at ten days post‐challenge. Commercial vaccine Vibrogen‐2 reduced V. anguillarum tissue colonization and delayed mortality but did not confer immune protection to C. lumpus against the V. anguillarum i.p. challenge.     

Genetic variability in four hatchery strains of coho salmon, Oncorhynchus kisutch (Walbaum), in Chile

Coho salmon, Oncorhynchus kisutch (Walbaum), is intensively cultured in Chile. An increasing proportion of the eggs necessary to sustain the culture are locally produced by some hatcheries. However, there is no information about the origin or the genetic variability in these strains. The present study analysed allozymic variability and its distribution within and between some commercial strains of coho salmon in southern Chile. The genetic variability was estimated using horizontal starch gel electrophoresis. Samples of coho salmon were obtained randomly from four Chilean hatcheries. Twenty‐five enzymatic systems were examined, representing 51 enzymatic loci. Eight loci showed variability in at least one strain, which represented a total polymorphism (P) of 15.7%. Only the PGM‐1* locus was variable in all strains. The remaining loci were fixed in at least one strain. Total heterozygosity (H_T) and within population heterozygosity (H_S) were 0.35% and 0.36% respectively. The index of genetic diversity (G_ST) was 1.5%. The results confirm previous reports of low genetic variability in cultured strains of coho salmon in Chile, below that observed in their native range, which suggests loss of the genetic variability caused by genetic drift or other causes in these strains.     

Effects of dietary lipid level and vegetable oil on fatty acid metabolism in Atlantic salmon (Salmo salar L.) over the whole production cycle

Changes in fatty acid metabolism in Atlantic salmon (Salmo salar) induced by vegetable oil (VO) replacement of fish oil (FO) and high dietary oil in aquaculture diets can have negative impacts on the nutritional quality of the product for the human consumer, including altered flesh fatty acid composition and lipid content. A dietary trial was designed to investigate the twin problems of FO replacement and high energy diets in salmon throughout the entire production cycle. Salmon were grown from first feeding to around 2 kg on diets in which FO was completely replaced by a 1:1 blend of linseed and rapeseed oils at low (14–17%) and high (25–35%) dietary oil levels. This paper reports specifically on the influence of diet on various aspects of fatty acid metabolism. Fatty acid compositions of liver, intestinal tissue and gill were altered by the diets with increased proportions of C₁₈ polyunsaturated fatty acids and decreased proportions of n-3 highly unsaturated fatty acids (HUFA) in fish fed VO compared to fish fed FO. HUFA synthesis in hepatocytes and enterocytes was significantly higher in fish fed VO, whereas β-oxidation was unaltered by either dietary oil content or type. Over the entire production cycle, HUFA synthesis in hepatocytes showed a decreasing trend with age interrupted by a large peak in activity at seawater transfer. Gill cell prostaglandin (PG) production showed a possible seasonal trend, with peak activities in winter and low activities in summer and at seawater transfer. PG production in seawater was lower in fish fed the high oil diets with the lowest PG production generally observed in fish fed high VO. The changes in fatty acid metabolism induced by high dietary oil and VO replacement contribute to altered flesh lipid content and fatty acid compositions, and so merit continued investigation to minimize any negative impacts that sustainable, environmentally-friendly and cost-effective aquaculture diets could have in the future. Abbreviations: FO - fish oil; HUFA - highly unsaturated fatty acids acids (carbon chain length ≥C ₂₀ with ≥3 double bonds); LO - linseed oil; RO - rapeseed oil; VO - vegetable oil. This revised version was published online in July 2006 with corrections to the Cover Date.     

An experimental study of the susceptibility of Atlantic salmon fry, Salmo salar L., to viral haemorrhagic septicaemia

Abstract. Infection trials using two serotypes of VHS viruses (type 1 and 23/75) demonstrated that Atlantic salmon fry were susceptible to the disease when injected intraperitoneally (i.p.) with 10³ pfu of virus/fish but resistant to infection by a bath method when exposed for 3 h in water containing 5 × 10⁴ pfu of virus/ml. In the i.p.-infected fish, mortality reached 78 and 67% within 13 days with VHSV₁ nad 23/75 serotypes, respectively. High virus yields were recovered from infected fish and virus shedding was demonstrated by the onset of VHS in rainbow trout kept in the outflow water from the aquaria containing infected salmon. Neither mortality nor virus shedding occurred in salmon infected by the water route but virus multiplication was demonstrated in 2 of 60 fish with VHSV₁ and 3 of 60 fish with virus 23/75. On day 79 post-infection the sera from surviving salmon of both i.p. and bath infection trials exhibited good neutralizing titres (around 1000) against the homologous viruses.     

Preservation Methods for Retaining N-3 Polyunsaturated Fatty Acids in Alaska Coho Salmon (Oncorhynchus kisutch) Products

Abstract

Coho salmon (Oncorhynchus kisutch) fillets were processed using five different methods (smoking, canning, freezing, acidifying, and salting) to evaluate the effect of preservation choice on the quality of polyunsaturated fatty acids (PUFA). Salmon preserved by smoking, canning, or freezing retained higher values of total fatty acids, including n-3 PUFAs such as eicosapentaenoic acid and docosahexaenoic acid. Salting and acidifying (pickling) treatments resulted in a significant decrease in PUFAs. The results of this study are intended to provide direction for handling and storage of salmon to retain the maximum levels of high-value n-3 PUFAs.     

Pharmacokinetics and bioavailabilities of 14C-keto-carotenoids, astaxanthin and canthaxanthin, in rainbow trout, Oncorhynchus mykiss

The pharmacokinetics and bioavailabilities of ¹⁴C‐astaxanthin and ¹⁴C‐canthaxanthin were studied in the blood of rainbow trout following intra‐arterial (i.a.) and oral (p.o.) administration. Sixteen months old 1 kg trout were cannulated in the dorsal aorta. [6,7,6′,7′‐¹⁴C]‐keto‐carotenoids were administered i.a. and p.o. at a dose of 573.5 kBq kg^?1 fish body weight for astaxanthin and 836.2 kBq kg^?1 fish body weight for canthaxanthin. After i.a. distribution, total body clearance (Cl_tot) was 17.30±20.29 mL kg^?1 of fish h^?1 for ¹⁴C‐canthaxanthin and 3.30±1.50 mL kg^?1 of fish h^?1 for ¹⁴C‐astaxanthin. The volume of distribution at steady‐state (V_ss) was 208.32±124.79 mL kg^?1 of fish and 71.84±64.15 mL kg^?1 of fish for ¹⁴C‐canthaxanthin and ¹⁴C‐astaxanthin respectively. Less than 0.4% of the administered radioactivity was recovered in urine. Radioactivity (expressed as percent of the dose) excreted in the bile of fish that received ¹⁴C‐canthaxanthin by i.a. route was 20‐fold higher than that observed for fish treated p.o. This ratio was lower for ¹⁴C‐astaxanthin (7.6‐fold). The mean keto‐carotenoid bioavailabilities calculated were 10–15% for both compounds. Findings suggest one daily astaxanthin application is preferable, while 12‐h time intervals between applications are preferable for canthaxanthin.     

Piscine orthoreovirus‐3 is prevalent in wild seatrout (Salmo trutta L.) in Norway

In 2017, a PCR‐based survey for Piscine orthoreovirus‐3 (PRV‐3) was conducted in wild anadromous and non‐anadromous salmonids in Norway. In seatrout (anadromous Salmo trutta L.), the virus was present in 16.6% of the fish and in 15 of 21 investigated rivers. Four of 221 (1.8%) Atlantic salmon (Salmo salar L.) from three of 15 rivers were also PCR‐positive, with Ct‐values indicating low amounts of viral RNA. All anadromous Arctic char (Salvelinus alpinus L.) were PCR‐negative. Neither non‐anadromous trout (brown trout) nor landlocked salmon were PRV‐3 positive. Altogether, these findings suggest that in Norway PRV‐3 is more prevalent in the marine environment. In contrast, PRV‐3 is present in areas with intensive inland farming in continental Europe. PRV‐3 genome sequences from Norwegian seatrout grouped together with sequences from rainbow trout (Oncorhynchus mykiss Walbaum) in Norway and Coho salmon (Oncorhynchus kisutch Walbaum) in Chile. At present, the origin of the virus remains unknown. Nevertheless, the study highlights the value of safeguarding native fish by upholding natural and artificial barriers that hinder introduction and spread, on a local or national scale, of alien fish species and their pathogens. Accordingly, further investigations of freshwater reservoirs and interactions with farmed salmonids are warranted.     

Development of a reproducible infectious pancreatic necrosis virus challenge model for Atlantic salmon, Salmo salar L.

Atlantic salmon smolts, previously unexposed to infectious pancreatic necrosis virus (IPNV), were placed into tanks of sea water at 10 °C. After 4 weeks, 40 fish were injected intraperitoneally (i.p.) with homogenized and filter‐sterilized kidney material obtained from salmon with clinical IPN in a marine farm in Shetland. The injected fish were cohabited with 40 untreated fish. Mortalities began in the injected fish on day 7 and reached a peak of 48% on day 14. In the cohabitation group, mortalities began on day 14 and reached a peak of 70% on day 27. The IPNV in the Shetland kidney homogenate was cultured in Chinook salmon embryo (CHSE) cells and passed twice. This cultured virus was injected i.p. into fish at various doses ranging from 10 to 10⁷ TCID₅₀ fish^?1 4 weeks after seawater transfer. Challenge tanks contained 30 injected fish and 30 cohabitees. Mortality rates and levels were dose‐dependent. The highest dose used resulted in a similar mortality pattern as obtained with a similar dose of the Shetland kidney homogenate, indicating that virulence was retained after two passes in tissue culture. Even with the lowest dose, mortality reached 12% in the injected group and 23% in the cohabitees. The IPNV titres were high (10⁶?10⁹ i.u. g^?1 kidney) in fish which died during the experiment and low (<10⁵ i.u. g^?1 kidney) or undetectable in surviving fish. The cultured virus (pass 3) was used in a challenge model where the population density of fish in the tanks was high (50 injected and 50 cohabitees) or low (15 injected and 15 cohabitees). In the high stocking density tank, mortalities peaked at about 35% in the injected group and at 52% in the cohabitees. In the low stocking density tank, mortalities peaked at about 40% in the injected fish but no mortality occurred in the cohabitees. However, IPNV was detected (up to 10⁴ i.u. g^?1 kidney) in 82% of cohabitees sampled on day 30. These data suggest that lethal lateral transmission of the virus is dependent on the infectious pressure from the injected group. A further trial was conducted to investigate the effect of time post‐seawater transfer on the susceptibility of post‐smolts to IPN. Groups of fish were challenged every 2 weeks from week 0–10. Few mortalities occurred at week 0 and virus titres were high in these fish. Most survivors became carriers, some with titres >10⁶ i.u. IPNV g^?1 kidney. From 2 to 10 weeks after seawater transfer, mortalities in both injected and cohabitees were substantial with viral titres >10⁷ i.u. g^?1 kidney. Survivors had lower titres and in many virus was undetectable. Throughout the experiments, moribund fish were sampled for histology and all showed typical IPN histopathology.     

Humoral response and susceptibility of five full-sib families of Atlantic salmon, Salmo salar L., to the haemoflagellate, Cryptobia salmositica

Susceptibility and antibody production against pathogenic and vaccine strains of the haemoflagellate, Cryptobia salmositica were investigated in five full‐sib families (A–E) of Atlantic salmon, Salmo salar. Humoral response and susceptibility of families were compared within three treatments: infection, vaccination and vaccination followed by challenge. Parasitaemias caused by the vaccine strain of C. salmositica were considerably lower than those caused by the pathogenic strain. All vaccinated families were protected when challenged with the pathogenic strain. Family B had significantly lower parasitaemias (with both strains) than the other families. When naïve fish were infected with the pathogenic strain, this family had a significantly lower and earlier peak parasitaemia (4.3 ±1.3 × 10⁶ parasites mL^?1 blood at 3 weeks post‐infection; w.p.i.) than the other families. Family C had the highest peak (11.1 ± 1.2 × 10⁶ parasites mL^?1 blood), which occurred at 4 w.p.i. Antibodies against C. salmositica were detected earlier in Family B (3 w.p.i.) than in Family C (5 w.p.i.). This demonstrates an association of increased susceptibility with a delayed antibody response. Western immunoblot identified antibodies against 112, 181 and 200 kDa antigens earlier in more resistant fish (Family B). Antigenic stimulation leading to a stronger antibody response was shown with the vaccine strain and in the later stages of infection.     

Distribution,abundance and growth of juvenile salmonids off the coast of Oregon and Washington,summer (1980)

Juvenile salmonids (< 50 cm) were sampled by purse seine off the Pacific coast from Tillamook Bay, Oregon, to Copalis Head, Washington, during the period May through September (1980). Temporal distribution and abundance of the major Columbia River species were determined. Spring chinook salmon (Oncorhynchus tshatuytscha) and steel head (Salmo gairdneri) were present only during early cruises and were distributed almost entirely in the Columbia River plume and the sample area to the north. Coho salmon (O. kisutch) and fall chinook salmon were distributed more uniformly throughout the sampling area and were relatively abundant throughout the sampling period. Concentrations of fish were found only within 28 km of the shore. A number of fish that had been marked before or during their outmigration from the Columbia River system were recaptured. It appeared possible that with concentrated sampling in areas with high fish abundances, sufficient numbers of marked juvenile salmonids could be captured to provide relative survival estimates between different stocks of Columbia River fish.     

Effect of acid environments on cortisol and cortisol receptor activity in Atlantic salmon,Salmo salar

The cytosol and nuclear extract of gill tissue obtained from laboratory held Atlantic salmon,Salmo salar manifested saturable cortisol binding of high affinity and low capacity (cytosol: K_a = 0.198 ± 0.024 × 10⁹/M, N_max = 116.8 ± 20.8 fmol/mg protein; nuclear extract: K_a = 0.823 ± 0.057 × 10⁷/M, N_max = 1563 ± 330 fmol/mg protein; n = 4). The cytosol receptor activity displayed high steroid and tissue specificity and a single binding peak at 191,000 Da following gel permeation chromatography. Atlantic salmon exposed for 3 or 8 months to waters from the Medway River (pH about 5.1), the Westfield River (pH about 4.8) and calcium carbonate treated Westfield River (pH about 5.6) showed no gill cytosol receptor activity. Cortisol receptor activity in the gill nuclear extracts from fish in limed Westfield River water in December (3 months) was less than half the activity in the fish treated with Medway River water (p < 0.05) although the plasma cortisol values were not different. In May (8 months), the plasma cortisol of fish in limed water was almost twice that of the fish held in acid Westfield River water (p = 0.058).     

Tissue and organ distribution of 14C‐activity in dextrin‐adapted Atlantic salmon after oral administration of radiolabelled 14C1‐glucose

Accumulation of ¹⁴C in various tissues and organs was studied in three different groups of 0.8‐kg Atlantic salmon Salmo salar force‐fed with ¹⁴C₁‐glucose in order to evaluate if metabolism of glucose depended on adaptation to dietary carbohydrate level. The salmon had been fed diets supplemented with 0, 100 and 200 g maize dextrin kg^?1 for 10 months before the experiment. The fish were force‐fed 6.65 × 10⁴ Bq of ¹⁴C₁ glucose kg^?1 BW, in gelatin capsules. Fish for analysis were obtained 16 h later. ¹⁴C was measured in blood plasma, gill, kidney, liver and white muscle, and in lipid extract of liver. The liver contained most ¹⁴C, followed by heart, blood plasma, gill and liver lipid extract, while kidney and muscle contained the least ¹⁴C per gram or millilitre tissue. The muscle contained most radioactivity, on an estimated total tissue basis, followed by liver, blood plasma, gill, liver lipid extract, kidney and heart tissue. Thirty‐eight per cent of the orally administered ¹⁴C was recovered in the salmon adapted to the diet without dextrin after 16 h. This was significantly (P < 0.05) higher than the 30% and 32% recovered in the salmon adapted to diets with 10% and 20% dextrin. This effect on adaptation to dietary dextrin level in glucose uptake or metabolism was supported by a trend (P < 0.10) toward higher radioactivity per gram or millilitre of each individual tissue in the fish adapted to the diet without dextrin, when compared with the other two adaptation regimes.     

Effects of 3,5,3′-triiodo-L-thyronine (T3) and 6-n-propyl-2-thiouracil (PTU) on growth of GH-transgenic coho salmon, Oncorhynchus kitsutch

GH-transgeniccoho salmon (Oncorhynchus kitsutch) juveniles were fed diets containing 3,5,3-triiodo-L-thyronine (T₃; 30 ng/g fish) or 6-n-propyl-2-thiouracil (PTU; 20 ug/g fish), to assess the effect of these drugs on the physiology, growthand survival in comparison with untreated transgenicand non-transgenic salmon. After 84 days, food intake, feed efficiency, survival, growth, hepato-somatic index (HSI), viscera-somatic index (VSI), plasma L-thyroxine (T₄), T₃and growth hormone (GH) levels,and cranial morphological abnormalities were determined. Growth of transgenic salmon was significantly faster than the nontransgenic salmon,and was increased by exogenous T₃and reduced by PTU. Food intake of transgenic salmon was higher than that of the nontransgenic group, but was reduced by exogenous PTU administration. Food conversion efficiency of transgenic salmon was lower than that of nontransgenic salmon,and also was increased by T₃ but reduced by PTU in the transgenic fish. The survival rate in all transgenic groups was significantly higher than that of nontransgenic,and transgenic T₃and PTU treatment groups showed higher survivals than the transgenic-control group. The HSIand VSI of the transgenic fish were higher than the nontransgenic fish;and both parameters in the transgenic salmon were increased by PTU, but reduced by T₃. The plasma T₄ level in transgenic salmon was approximately 1.5-fold higher relative to the nontransgenic fish, whereas no difference was observed among the transgenic groups. Plasma T₃ levels in transgenic salmon were also approximately 2-fold higher relative to the nontransgenic fish. However, the plasma T₃ level in transgenic animals was increased by exogenous T₃ administration, but was reduced by exogenous PTU to that observed in nontransgenic salmon. The plasma GH level of transgenic fish was higher than that of the nontransgenic salmon,and the level was increased by the exogenous T₃, whereas exogenous PTU did not reduce significantly GH levels in transgenic salmon. Transgenic fish also displayed cranium, jawand opercular abnormalities typical of the effects of this gene construct incoho salmon, indicating that some imbalance in growth processes has been induced. However, these abnormalities (especially cranial disruptions) were diminished by administration of exogenous PTU. In conclusion, exogenous T₃and PTU treatments can induce hyperthyroidismand hypothyroidism, respectively,and have inverse effects on growthand skeletal abnormalities of transgenic salmon constitutively expressing GH.     

Studies on the inactivation of selected viral and bacterial fish pathogens at high pH for waste disposal purposes

This study investigated the use of alkaline hydrolysis at ambient temperature for inactivation of selected fish pathogens in fish tissues under conditions approximating those that are likely to be found in the aquaculture industry. Infectious salmon anaemia virus (ISAV) and Lactococcus garvieae have been determined in a previous study to be the most resistant virus and bacteria to pH 12 from a wide range of viruses and bacteria tested. They were spiked at high titres into fish extracts that were then treated with 1 m sodium hydroxide (NaOH). Viable L. garvieae was not detected in the treated fish extract after 1 h, and ISAV was not detected after 24‐h exposure. Field mortalities of Atlantic salmon, Salmo salar L., caused by infectious pancreatic necrosis virus were treated by alkaline hydrolysis at ambient temperature. The macerated fish mortalities contained a high titre of virus (3.38 × 10⁸ TCID₅₀ g^?1) that was reduced to approximately 2.2 × 10³ TCID₅₀ g^?1 after 24‐h exposure to NaOH, and virus was not detected after exposure for 48 h. The results suggest that alkaline hydrolysis at ambient temperature has potential as a biosecure treatment method for fish by‐products containing fish pathogens.